Safety and Feasibility of Repeatable Hepatic Vascular Isolation Chemotherapy: A Pilot Study
- 25 March 2016
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 23 (11) , 3699-3708
Abstract
The authors herein describe a novel method of repeatable hepatic isolation using an implantable access system allowing simultaneous control of hepatic arterial and portal flows by multiple endovascular catheters. The aim of this study was to assess the feasibility and safety of the system and to compress standard intravenous chemotherapy into 4 weeks of targeted intra-arterial delivery. An arterial access system was implanted to the axillary artery via an anastomosis. Infusions of oxaliplatin were performed biweekly for 4 weeks, using balloon catheters to achieve hepatic isolation and segmental selectivity for 20-25 min. Fifty-seven treatments under general anesthetic were performed in ten patients with inoperable chemotherapy-refractory metastatic colorectal cancer. Systemic, intrahepatic, and hepatic venous pressures were recorded to assess vascular isolation, and platinum levels were measured to assess chemotherapy distribution. Pressure verified, multiple day-only hepatic vascular isolation infusions were achieved in nine of ten patients, with a single patient receiving multiple hepatic arterial infusions. Positron emission tomography-computed tomography (PET-CT) imaging confirmed partial response in three of ten patients and stable disease in three of ten patients. Systemic toxicity was minimal as all treatment-related gastrointestinal and neuropathic symptoms reported throughout the 4 weeks were grades 1-2. Intra-arterial chemotherapy infusions with hepatic vascular isolation can be achieved repeatedly with targeted selectivity and minimal complications using an implantable multicatheter access system. Oxaliplatin infusions over a 4-week period may achieve tumor response in selected patients in the salvage setting. The technique should be further assessed in a phase Ib/II study.Keywords
This publication has 12 references indexed in Scilit:
- Phase II Trial of Hepatic Artery Infusional and Systemic Chemotherapy for Patients With Unresectable Hepatic Metastases From Colorectal CancerAnnals of Surgery, 2015
- Hypertensive extracorporeal limb perfusion for critical limb ischemiaJournal of Vascular Surgery, 2013
- Outcome of Patients with Colorectal Liver Metastasis: Analysis of 1,613 Consecutive CasesAnnals of Surgical Oncology, 2012
- The Hepatic Microcirculation: Mechanistic Contributions and Therapeutic Targets in Liver Injury and RepairPhysiological Reviews, 2009
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid TumorsJournal of Nuclear Medicine, 2009
- Hypertensive extracorporeal limb perfusion (HELP): A new technique for managing critical lower limb ischemiaJournal of Vascular Surgery, 2008
- Hepatic Arterial Infusion of Oxaliplatin and Intravenous LV5FU2 in Unresectable Liver Metastases from Colorectal Cancer after Systemic Chemotherapy FailureAnnals of Surgical Oncology, 2007
- A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancerBritish Journal of Surgery, 2006
- Hepatic Arterial Oxaliplatin Infusion Plus Intravenous Chemotherapy in Colorectal Cancer With Inoperable Hepatic Metastases: A Trial of the Gastrointestinal Group of the Fédération Nationale des Centres de Lutte Contre le CancerJournal of Clinical Oncology, 2005
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993